MedPath

Study regarding appropriate intervals between two doses of varicella vaccine

Not Applicable
Conditions
Varicella
Registration Number
JPRN-UMIN000013675
Lead Sponsor
Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not available for vaccination.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The IgG and IgM antibodies and CMI with interferon-gamma release assay before and at 1 and 13 months after vaccination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath